The patient with AML was receiving multiple transfusions of both red cells and platelets, and thus presented as a case of platelet refractoriness.
Controversy exists as to whether myeloma and AML originate from a single haematopoietic progenitor or arise from different cell lineages.
However, risk stratification of AML based on these methods is still incomplete.
Acute lymphoid leukemia (ALL) is more common among Caucasians than among African-Americans, while acute myeloid leukemia (AML) affects both races equally.
Acute myelocytic leukemia (AML) has a poorer prognosis rate than acute lymphocytic leukemias (ALL) and the chronic leukemias.
